We're posting up notes from the Sohn Investment Conference in New
York, produced in partnership with Bloomberg LINK. Next up is Mariko Gordon of Daruma Capital who pitched three ideas: Electronics For Imaging (EPII), H.B. Fuller (FUL) and Pacira Pharmaceuticals (PCRX).
Mariko Gordon's Sohn Conference Presentation
Talked about how everyone has short holding periods of stocks now. Three ideas.
Long: Electronics for Imaging (EFII). Conversion from analog to digital printing. Company makes large-scale inkjet printers for printing tile, facades, even surfboards. Razor/blade model. They were not selling ink, but will be soon. $60 PT, 20x $3/share in 2016.
Long: HB Fuller (FUL). Specialty adhesives company. Cut 13 plants down to 7, 1400 employees down to 1000. Reduced SKUs by 45%. Only 15% EBITDA margin target though. $70 PT, stock is $45 now. Bull case target is $90, needs more growth.
Long: Pacira Pharma (PCRX). Pain killer medicine.. Costs 100x more than the generic. Lasts up to 72 hours, vs other up to 8 hours. Drug is Exparel. PT $150, stock is $70 now. Early stage company now, based on 10% market share. $250 bull case PT on 20% market share.
Be sure to check out the rest of the presentations from the 2014 Sohn Investment Conference.
Tuesday, May 6, 2014
Mariko Gordon: Long Electronics For Imaging, H.B. Fuller, Pacira Pharmaceuticals (Sohn Conference Presentation)
Labels:
daruma capital,
EFII,
FUL,
ira sohn conference,
mariko gordon,
PCRX
blog comments powered by Disqus